missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ TACR1 Monoclonal Antibody (ZN003)

Mouse Monoclonal Antibody
Brand: Invitrogen™ 396100
This item is not returnable.
View return policy
Description
TACR1 Monoclonal Antibody for Western Blot, ICC/IF, ELISA
Tachykinin Receptor 1, a member of the Tachykinin Receptor subfamily, is involved in the mediation of phosphatidylinositol metabolism by the tachykinin substance P, also referred to as neurokinin 1. It is associated with the management of depression, anxiety, and stress. It is also involved in regulating behavioral responses, neuronal survival, and cardiovascular and respiratory functions. The tachykinin receptor 1 is implicated in the progression of rheumatoid arthritis and osteoarthritis. Two variants of the tachykinin receptor 1 are produced by alternative splicing. Tachykinin receptor 1 has been reported primarily in brain, and in blood lymphocytes, nose, small intestine, and stomach. ESTs have been isolated from brain and spleen libraries.
Specifications
| TACR1 | |
| Monoclonal | |
| 0.5 mg/mL | |
| PBS with 0.1% sodium azide; pH 7.4 | |
| P14600, P25103, P30548 | |
| Tacr1 | |
| Synthetic peptide derived from an internal sequence of the human, mouse, and rat NK1 receptor proteins. | |
| 100 μg | |
| Primary | |
| Human, Mouse, Rat, Insect | |
| Antibody | |
| IgG1 κ |
| ELISA, Western Blot, Immunocytochemistry | |
| ZN003 | |
| Unconjugated | |
| Tacr1 | |
| neurokinin 1 receptor; neurokinin receptor 1; neurokinin receptor subtype NK1; neurokinin-1 receptor; Nk1 receptor; NK-1 receptor; Nk1r; NK-1R; NKIR; SPR; substance p receptor; substance-P receptor; TAC1R; tachykinin receptor 1; tachykinin receptor 1 (substance P receptor; neurokinin-1 receptor); TACR1; truncated neurokinin-1 receptor | |
| Mouse | |
| Protein A | |
| RUO | |
| 21336, 24807, 6869 | |
| -20°C | |
| Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction